Friday, October 2, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleNasdaq· July 28, 2026

Stocks Mixed on Earnings Results and Weakness in Chipmakers

View original at nasdaq.com
Stocks Mixed on Earnings Results and Weakness in Chipmakers The S&P 500 Index ($SPX) (SPY) today is up +0.05%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.738%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -1.12%…
Opening lines of the source · Nasdaq · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Claimed to have struck facilities linked to Saudi Aramco in the Red Sea port towns of Jizan and Yanbu on Saturday

    60% confidence
  • Q2 earnings may increase by +23%, close to Q1's blowout earnings of +30%, which was more than double the +12% analysts had expected

    60% confidence
  • Forecasting Q3 net sales of $1.95 billion to $2.05 billion, weaker than the consensus of $2.11 billion

    60% confidence
  • Raised the possibility of intensified action against Iran

    60% confidence
  • Reported Q2 net sales of $10.40 billion, above the consensus of $10.03 billion

    60% confidence
  • Raising its full-year comparable EPS forecast to up +9% to +10% from a previous view of +8% to +9%

    60% confidence
  • Boosting full-year revenue forecast to $17.28 billion to $17.48 billion from a previous forecast of $17.15 billion to $17.35 billion, stronger than consensus of $17.28 billion

    60% confidence
  • Cutting full-year adjusted EBITDA estimate to $850 million to $925 million from a previous forecast of $940 million to $1.02 billion, below consensus of $970.3 million

    60% confidence
  • Downgraded RXO to sell from hold with a price target of $19

    60% confidence
  • Upgraded Intuitive Surgical to buy from hold with a price target of $500

    60% confidence
  • Forecasting Q3 core sales of $4.9 billion to $5.0 billion, the midpoint below the consensus of $5.0 billion

    60% confidence
  • Reported adjusted EPS of $3.70, better than the consensus of $3.51, and raised full-year adjusted EPS forecast to $11.80 to $12.20

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com